Are we in the midst of a psychedelic renaissance? If so, what can we learn about the present moment through the history of psychedelic experiments in the past? Matt Oram discusses contemporary debates about LSD and MDMA and brings much-needed context with his new book, The Trials of Psychedelic Therapy: LSD Psychotherapy in America (Johns Hopkins University Press, 2018), Oram talks about the role of psychiatry and the pharmaceutical industry as well the field of drug regulation. He underlines, too, that the history of psychedelics is a lot more complicated than researchers have previously suggested.
Lucas Richert is an associate professor in the School of Pharmacy at the University of Wisconsin, Madison. He studies intoxicating substances and the pharmaceutical industry. He also examines the history of mental health.